722 related articles for article (PubMed ID: 34090145)
1. Transcutaneous Vagus Nerve Stimulation (t-VNS) and epilepsy: A systematic review of the literature.
Lampros M; Vlachos N; Zigouris A; Voulgaris S; Alexiou GA
Seizure; 2021 Oct; 91():40-48. PubMed ID: 34090145
[TBL] [Abstract][Full Text] [Related]
2. Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial.
Yang H; Shi W; Fan J; Wang X; Song Y; Lian Y; Shan W; Wang Q
Neurotherapeutics; 2023 Apr; 20(3):870-880. PubMed ID: 36995682
[TBL] [Abstract][Full Text] [Related]
3. Transcutaneous auricular vagus nerve stimulation for pediatric epilepsy: study protocol for a randomized controlled trial.
He W; Wang XY; Zhou L; Li ZM; Jing XH; Lv ZL; Zhao YF; Shi H; Hu L; Su YS; Zhu B
Trials; 2015 Aug; 16():371. PubMed ID: 26292720
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy.
Aihua L; Lu S; Liping L; Xiuru W; Hua L; Yuping W
Epilepsy Behav; 2014 Oct; 39():105-10. PubMed ID: 25240121
[TBL] [Abstract][Full Text] [Related]
5. Vagus nerve stimulation for conservative therapy-refractive epilepsy and depression.
Möbius H; Welkoborsky HJ
Laryngorhinootologie; 2022 May; 101(S 01):S114-S143. PubMed ID: 35605616
[TBL] [Abstract][Full Text] [Related]
6. An alternative therapy for drug-resistant epilepsy: transcutaneous auricular vagus nerve stimulation.
Rong P; Liu A; Zhang J; Wang Y; Yang A; Li L; Ben H; Li L; Liu R; He W; Liu H; Huang F; Li X; Wu P; Zhu B
Chin Med J (Engl); 2014; 127(2):300-4. PubMed ID: 24438620
[TBL] [Abstract][Full Text] [Related]
7. The role of vagus nerve stimulation in genetic etiologies of drug-resistant epilepsy: a meta-analysis.
Hajtovic S; LoPresti MA; Zhang L; Katlowitz KA; Kizek DJ; Lam S
J Neurosurg Pediatr; 2022 Jun; 29(6):667-680. PubMed ID: 35303699
[TBL] [Abstract][Full Text] [Related]
8. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
9. Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: A critical review.
Toffa DH; Touma L; El Meskine T; Bouthillier A; Nguyen DK
Seizure; 2020 Dec; 83():104-123. PubMed ID: 33120323
[TBL] [Abstract][Full Text] [Related]
10. An analysis of quality of life (QOL) in patients with epilepsy and comorbid psychogenic nonepileptic seizures (PNES) after vagus nerve stimulation (VNS).
Vivas AC; Reitano CJ; Waseem H; Benbadis SR; Vale FL
Epilepsy Behav; 2017 Aug; 73():208-213. PubMed ID: 28651170
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Treatment with Transcutaneous Vagus Nerve Stimulation in 17 Patients with Refractory Epilepsy Evaluated by Electroencephalogram, Seizure Frequency, and Quality of Life.
Liu A; Rong P; Gong L; Song L; Wang X; Li L; Wang Y
Med Sci Monit; 2018 Nov; 24():8439-8448. PubMed ID: 30467307
[TBL] [Abstract][Full Text] [Related]
12. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
[TBL] [Abstract][Full Text] [Related]
13. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
Chambers A; Bowen JM
Ont Health Technol Assess Ser; 2013; 13(18):1-37. PubMed ID: 24228081
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; a systematic review.
Redgrave J; Day D; Leung H; Laud PJ; Ali A; Lindert R; Majid A
Brain Stimul; 2018; 11(6):1225-1238. PubMed ID: 30217648
[TBL] [Abstract][Full Text] [Related]
15. Long-term seizure and psychosocial outcomes of vagus nerve stimulation for intractable epilepsy.
Wasade VS; Schultz L; Mohanarangan K; Gaddam A; Schwalb JM; Spanaki-Varelas M
Epilepsy Behav; 2015 Dec; 53():31-6. PubMed ID: 26515157
[TBL] [Abstract][Full Text] [Related]
16. Transcutaneous auricular vagus nerve stimulation as a complementary therapy for pediatric epilepsy: a pilot trial.
He W; Jing X; Wang X; Rong P; Li L; Shi H; Shang H; Wang Y; Zhang J; Zhu B
Epilepsy Behav; 2013 Sep; 28(3):343-6. PubMed ID: 23820114
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous vagal nerve stimulatio (t-VNS): An adjunctive treatment option for refractory epilepsy.
Barbella G; Cocco I; Freri E; Marotta G; Visani E; Franceschetti S; Casazza M
Seizure; 2018 Aug; 60():115-119. PubMed ID: 29940349
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous vagus nerve stimulation in the treatment of drug-resistant epilepsy.
von Wrede R; Surges R
Auton Neurosci; 2021 Nov; 235():102840. PubMed ID: 34246121
[TBL] [Abstract][Full Text] [Related]
19. Vagus nerve stimulation for the treatment of epilepsy: things to note on the protocols, the effects and the mechanisms of action.
Abdullahi A; Etoom M; Badaru UM; Elibol N; Abuelsamen AA; Alawneh A; Zakari UU; Saeys W; Truijen S
Int J Neurosci; 2024 Jun; 134(6):560-569. PubMed ID: 36120993
[TBL] [Abstract][Full Text] [Related]
20. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial.
Ryvlin P; Gilliam FG; Nguyen DK; Colicchio G; Iudice A; Tinuper P; Zamponi N; Aguglia U; Wagner L; Minotti L; Stefan H; Boon P; Sadler M; Benna P; Raman P; Perucca E
Epilepsia; 2014 Jun; 55(6):893-900. PubMed ID: 24754318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
